Nonmotor features of Parkinson's disease subtypes
暂无分享,去创建一个
[1] H. Shill,et al. Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction , 2009, Acta Neuropathologica.
[2] K. Shannon,et al. Is alpha‐synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases , 2012, Movement disorders : official journal of the Movement Disorder Society.
[3] C. Zhong,et al. Nigral iron deposition occurs across motor phenotypes of Parkinson’s disease , 2012, European Journal of Neurology.
[4] W. Oyen,et al. Pallidal dysfunction drives a cerebellothalamic circuit into Parkinson tremor , 2011, Annals of neurology.
[5] K Ray Chaudhuri,et al. Non‐motor symptoms burden in treated and untreated early Parkinson's disease patients: argument for non‐motor subtypes , 2015, European journal of neurology.
[6] M. Vassallo,et al. Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype. , 2014, Neurodegenerative disease management.
[7] Ajay S. Kurani,et al. Differences in brain activation between tremor- and nontremor-dominant Parkinson disease. , 2012, JAMA neurology.
[8] C Adler,et al. Olfactory function in Parkinson's disease subtypes , 1994, Neurology.
[9] Marios Politis,et al. Parkinson's disease symptoms: The patient's perspective , 2010, Movement disorders : official journal of the Movement Disorder Society.
[10] J. Speelman,et al. Clinical heterogeneity in newly diagnosed Parkinson’s disease , 2008, Journal of Neurology.
[11] E. Tolosa,et al. Molecular and clinical prodrome of Parkinson disease: implications for treatment , 2010, Nature Reviews Neurology.
[12] L. Defebvre,et al. Cognitive and SPECT characteristics predict progression of Parkinson’s disease in newly diagnosed patients , 2004, Journal of Neurology.
[13] A. Lang,et al. Parkinson's disease subtypes: lost in translation? , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[14] Rachel J. Anderson,et al. Depression and anxiety related subtypes in Parkinson's disease , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[15] D. Dickson,et al. Neuropathology underlying clinical variability in patients with synucleinopathies , 2011, Acta Neuropathologica.
[16] M. Stern,et al. Milestones in Parkinson's disease—Clinical and pathologic features , 2011, Movement disorders : official journal of the Movement Disorder Society.
[17] E. Tolosa,et al. Multiple organ involvement by alpha‐synuclein pathology in Lewy body disorders , 2014, Movement disorders : official journal of the Movement Disorder Society.
[18] R. Barker,et al. The spectrum of nonmotor symptoms in early Parkinson disease , 2013, Neurology.
[19] K. Jellinger. Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts , 2012, Movement disorders : official journal of the Movement Disorder Society.
[20] Schiess,et al. Parkinson's disease subtypes: clinical classification and ventricular cerebrospinal fluid analysis. , 2000, Parkinsonism & related disorders.
[21] D. Aarsland,et al. The association between motor subtypes and psychopathology in Parkinson's disease. , 2009, Parkinsonism & related disorders.
[22] L. Defebvre,et al. Apathy in untreated early‐stage Parkinson disease: Relationship with other non‐motor symptoms , 2014, Movement disorders : official journal of the Movement Disorder Society.
[23] Giuseppe Orefice,et al. The Heterogeneity of Early Parkinson’s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients , 2013, PloS one.
[24] M. Vidailhet. [Heterogeneity of Parkinson's disease]. , 2003, Bulletin de l'Academie nationale de medecine.
[25] U. Dillmann,et al. Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.
[26] O. Hornykiewicz,et al. Globus pallidus dopamine and Parkinson motor subtypes , 2008, Neurology.
[27] H. Sagar,et al. A data‐driven approach to the study of heterogeneity in idiopathic Parkinson's disease: identification of three distinct subtypes , 1999, Movement disorders : official journal of the Movement Disorder Society.
[28] D. Aarsland,et al. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[29] Nikolaus Weiskopf,et al. Motor phenotype and magnetic resonance measures of basal ganglia iron levels in Parkinson's disease☆ , 2013, Parkinsonism & related disorders.
[30] S. Landau,et al. Parkinson's disease motor subtypes and mood , 2012, Movement disorders : official journal of the Movement Disorder Society.
[31] A. Tröster,et al. Parkinson's disease mild cognitive impairment: application and validation of the criteria. , 2014, Journal of Parkinson's disease.
[32] Thomas Foltynie,et al. The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. , 2009, Brain : a journal of neurology.
[33] Anette Schrag,et al. Why do patients with Parkinson’s disease fall? A cross-sectional analysis of possible causes of falls , 2015, npj Parkinson's Disease.
[34] Angelo Antonini,et al. Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effects , 2011, NeuroImage.
[35] P. Kempster,et al. Neuropathological findings in benign tremulous Parkinsonism , 2013, Movement disorders : official journal of the Movement Disorder Society.
[36] H. Braak,et al. Staging of brain pathology related to sporadic Parkinson’s disease , 2003, Neurobiology of Aging.
[37] T. Feng,et al. Clinical heterogeneity in patients with early-stage Parkinson’s disease: a cluster analysis , 2011, Journal of Zhejiang University SCIENCE B.
[38] L. Timmermann,et al. Parkinson’s Disease Subtypes Show a Specific Link between Dopaminergic and Glucose Metabolism in the Striatum , 2014, PloS one.
[39] David J. Brooks,et al. A Proposal for a Comprehensive Grading of Parkinson's Disease Severity Combining Motor and Non-Motor Assessments: Meeting an Unmet Need , 2013, PloS one.
[40] T Revesz,et al. A clinico-pathological study of subtypes in Parkinson's disease. , 2009, Brain : a journal of neurology.
[41] T. Robbins,et al. Heterogeneity of Parkinson’s disease in the early clinical stages using a data driven approach , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[42] K. Kashihara,et al. Cardiac 123I-MIBG uptake is reduced more markedly in patients with REM sleep behavior disorder than in those with early stage Parkinson's disease. , 2010, Parkinsonism & related disorders.
[43] S. Saiki,et al. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD , 2004, Journal of the Neurological Sciences.
[44] J. Marinus,et al. Relation of clinical subtypes in Parkinson's disease with survival , 2014, Movement disorders : official journal of the Movement Disorder Society.
[45] O. Tysnes,et al. Autonomic and sensory symptoms and signs in incident, untreated Parkinson's disease: Frequent but mild , 2011, Movement disorders : official journal of the Movement Disorder Society.
[46] J. Jankovic,et al. Variable expression of Parkinson's disease , 1990, Neurology.
[47] A. Espay,et al. Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement , 2014, Movement disorders : official journal of the Movement Disorder Society.
[48] H. Reichmann,et al. Olfactory Function in Parkinson's Disease , 2010 .
[49] Jeffrey M. Hausdorff,et al. Cognitive function and other non-motor features in non-demented Parkinson’s disease motor subtypes , 2015, Journal of Neural Transmission.
[50] G. Polesello,et al. Clinical predictors in Parkinson's disease , 2002, Neurological Sciences.
[51] Jean-François Gagnon,et al. New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. , 2015, JAMA neurology.
[52] Véronique Latreille,et al. Rapid eye movement sleep behavior disorder and subtypes of Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.
[53] K. Chaudhuri,et al. Non motor subtypes and Parkinson's disease. , 2016, Parkinsonism & related disorders.
[54] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment , 2009, The Lancet Neurology.
[55] E. Tolosa,et al. When does Parkinson's disease begin? , 2009, Movement disorders : official journal of the Movement Disorder Society.
[56] M. T. Pellecchia,et al. Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease , 2015, Movement disorders : official journal of the Movement Disorder Society.
[57] W. Heiser,et al. The identification of Parkinson's disease subtypes using cluster analysis: A systematic review , 2010, Movement disorders : official journal of the Movement Disorder Society.
[58] K. Chaudhuri,et al. The range and nature of non-motor symptoms in drug-naive Parkinson’s disease patients: a state-of-the-art systematic review , 2015, npj Parkinson's Disease.
[59] W. Koller,et al. When does Parkinson's disease begin? , 1992, Neurology.
[60] J. Trojanowski,et al. CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease , 2010, Neurology.
[61] K. Chaudhuri,et al. Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.
[62] Paolo Barone,et al. International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study , 2006, Movement disorders : official journal of the Movement Disorder Society.
[63] D. Aarsland,et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. , 2003, Archives of neurology.
[64] J. Marinus,et al. Motor patterns in Parkinson's disease: A data‐driven approach , 2009, Movement disorders : official journal of the Movement Disorder Society.
[65] K. Chaudhuri,et al. The impact of non‐motor symptoms on health‐related quality of life of patients with Parkinson's disease , 2011, Movement disorders : official journal of the Movement Disorder Society.
[66] E. Tolosa,et al. The Onset of Nonmotor Symptoms in Parkinson's disease (The ONSET PD Study) , 2015, Movement disorders : official journal of the Movement Disorder Society.
[67] Turi O. Dalaker,et al. Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease , 2012, Journal of Neurology, Neurosurgery & Psychiatry.